Three things to know:
1. OsseoGen is a dimethyl sulfoxide-free product, which eliminates the need to rinse and decant the tissue before implantation. It is delivered through an open-bore syringe.
2. OsseoGen takes about half the time to thaw, compared to other cellular bone matrixes currently available, according to the company.
3. Biologica’s debut product, ProteiOS, was launched for orthopedics and neurosurgery in 2015. The growth factor comprises allogenic bone marrow and can be used with the surgeon’s choice of scaffold or matrix.
More articles on biologics:
Dr. Alexander Vaccaro on the ‘secret sauce’ behind Rothman Orthopaedics’ Florida expansion
Renowned UK orthopedic surgeon investigated for collecting bones of 5,000+ patients
Dr. Farzin Kabaei on COVID-19 recovery, herd immunity & threats to private practice
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
